Skip to content
Screener

EyePoint, Inc. EYPT Operating Income

Operating Income at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.29B+19.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$93.34M-46.0%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$59.78M-1.2%
Regenxbio logo
RegenxbioRGNX
$29.26M+146%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$73.62M-37.3%
KLR
Kalaris TherapeuticsKLRS
-$11.83M-14.3%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Sales and marketing31353470
General and administrative14,24211,86229,48525,738
Total operating expenses97,88767,560185,809140,850
Loss from operations(97,380)(62,227)(184,606)(111,064)
Other (expense) income:
Interest and other income, net2,9102,8945,2546,536
Total other income, net2,9102,8945,2546,536
Net loss before income taxes$(94,470)$(59,333)$(179,352)$(104,528)

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s operating income?
EyePoint, Inc. (EYPT) reported operating income of -$97.38M in Q2 2026.
How has EyePoint, Inc.'s operating income changed year-over-year?
EyePoint, Inc.'s operating income decreased by 56.5% year-over-year, from -$62.23M to -$97.38M.
What is the long-term trend for EyePoint, Inc.'s operating income?
Over 4 years (2021 to 2025), EyePoint, Inc.'s operating income has grown at a 44.9% compound annual growth rate (CAGR), from -$55.28M to -$243.43M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about EyePoint, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude